|
Anti-VEGF Clinical Trials
2 actively recruiting trials
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- Shanghai Zhongshan Hospital1
- Shandong Cancer Hospital and Institute1
Indications
- Liver Disease2
- Liver Cancer2
- Hepatocellular Carcinoma2
- Cancer2
- Hepatic Artery Infusion Chemotherapy1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.